Zepp Health Corporation (ZEPP) Stock Forecast
ZEPP analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $43.86 average of analyst targets
- Upside to target
- +1,352.3% from the latest close
- Next earnings
- November 3, 2026
- 52-week range
- $3.02 – $49.83
ZEPP analyst ratings
1 analystsNumber of analysts at each rating.
ZEPP price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ZEPP earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$0.10 | −$0.10 | −$0.10 | −$1.97 | +94.9% | 1 |
| Next fiscal year (2027) | −$0.04 | −$0.04 | −$0.04 | −$0.10 | +60.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ZEPP revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (2026) | $2.04B | $2.04B | $2.04B | +14.2% | 1 |
| Next fiscal year (2027) | $2.17B | $2.17B | $2.17B | +6.5% | 1 |
ZEPP EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ZEPP revenue: reported and forecast
ZEPP EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | $0.01 | −$0.03 | −$0.03 | −$0.03 | −$0.10 | −1,100.0% | 1 up · 0 down |
| Next fiscal year (2027) | $0.07 | $0.05 | $0.05 | $0.05 | −$0.04 | −157.1% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ZEPP earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ZEPP beat in 1 of 7.
What analysts expect from ZEPP
1 analysts cover Zepp Health; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $43.86, 1,352.3% above the latest close of $3.02. Analysts expect earnings of −$0.10 per share for 2026, +94.9% from a year earlier. For 2027 the average estimate is −$0.04 per share on revenue of $2.2 billion. Zepp Health beat the EPS estimate in 1 of the last 7 quarters.
Related: ZEPP income statement, ZEPP key metrics, ZEPP chart. See the ZEPP stock overview for the latest quote and news.
ZEPP forecast FAQ
What is Zepp Health's price target?
The average analyst price target for Zepp Health is $43.86, 1,352.3% above the latest close of $3.02.
Is Zepp Health a buy, hold or sell?
Of 1 analysts covering Zepp Health, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Zepp Health's EPS forecast?
Analysts forecast −$0.10 per share for 2026 (range −$0.10 to −$0.10); for 2027 the estimate is −$0.04.
What is Zepp Health's revenue forecast?
The average revenue estimate for 2026 is $2.0 billion, growth of 14.2%; for 2027 it is $2.2 billion.
When does Zepp Health report earnings?
Zepp Health is expected to report results for the quarter ending September 30, 2026 on November 3, 2026.
Does Zepp Health usually beat earnings estimates?
Zepp Health reported EPS at or above the analyst estimate in 1 of the last 7 quarters.